Yi-Xin Zeng

16PUBLICATIONS
68CO-AUTHORS
Environmental epidemiologyMajor global burdens of diseaseMedical molecular engineering of nucleic acids and proteinsInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 15, 2026
EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk.

|Jun 18, 2025
R9AP is a common receptor for EBV infection in epithelial cells and B cells.

Yan Li, Hua Zhang, Cong Sun

|Jun 21, 2024
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection.

Ling Zhong, Wanlin Zhang, Hong Liu

|Feb 27, 2023
HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19.

Ruihua Wang, Ying Sun, Bo-Hua Kuang

|Apr 26, 2022
CRL2KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression.

Yang Liu, Yuewen Luo, Shumei Yan

|Apr 13, 2022
A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening.

Yong-Qiao He, Tong-Min Wang, Mingfang Ji

Pageof 3

Frequent Collaborators

5 joint publications

Xiaoxue Chen

5 joint publications

Lin Feng

5 joint publications

Mu-Sheng Zeng

5 joint publications

Song Gao